Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tuberculosis (TB) continues to be a major global health disaster, despite the widespread use of BCG and effective drug therapies. The development of an efficacious new TB vaccine would be an important component of disease control in the future. Many approaches are being utilised to enhance understanding of the requirements of a successful vaccine. Numerous vaccines are being designed and assessed in a series of animal models, with a few progressing to clinical trials. Here, the steps involved in the development and evaluation of TB vaccines will be discussed, including description of the most frequently used animal models and the processes involved in advancing vaccines to phase III trials.

Original publication

DOI

10.1111/j.1365-2249.2006.03306.x

Type

Journal article

Journal

Clin Exp Immunol

Publication Date

03/2007

Volume

147

Pages

401 - 411

Keywords

Animals, BCG Vaccine, Clinical Trials as Topic, Disease Models, Animal, Humans, Mice, Research Design, Tuberculosis, Tuberculosis Vaccines, Vaccination